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1. Introduction 
Astroglial filaments isolated from mouse optic 
nerve are composed of 2 major polypeptides with M r 
55 000 and 45 000 (referred to as P55 and P45 below; 
[ I ]). These two polypeptides occur in an approximate 
molar ratio of 1 : 1 under a variety of circumstances, 
i.e., in the normal and degenerated optic nerve in situ, 
in isolated 10 nm filaments, after being solubilised in 
a hypotonic medium, and in filaments reassembled in 
vitro, which suggests that they are closely associated. 
One-dimensional peptide map analyses have indicated 
that P55 is distinct from a-tubulin and that P45 is not 
a degradation product of P55. 
Considering that glial fibrillary acidic (GFA) pro- 
tein has so far been thought o comprise a single 
protein species (review [2]), and also that astroglial 
filaments isolated from human gliosed brain were 
mainly composed of a single species of polypeptide 
of 49 000 M r [3], the simultaneous occurrence of 
two polypeptides in our purified astroglial filaments 
re'quires explanation. 
An attempt to characterise these 2 polypeptides 
here indicates that the larger polypeptide ishomolo- 
gous to vimentin, the protein subunit of a type of 
intermediate filaments in many cells, especially in 
mesenchymal ceils [4-6], and that only P45 cross- 
reacts with anti:GFA protein antiserum. This finding 
is in accord with the coexistence of vimentin and 
GFA protein shown in the cytoskeleton of the rat 
optic nerve [7]. In contrast to the optic nerve, 
vimentin in the spinal cord cytoskeleton prevails 
only in immature animals, and becomes almost unde- 
tectable in adults. Interspecies differences in M r and 
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in one-dimensional peptide maps of GFA protein 
among rodent species are also shown. 
2. Materials and methods 
2.1. Cytoskeletal preparations from the optic nerve 
and spinal cord 
Male Wistar rats at various ages and adult male dd 
mice were used. The animals were killed by decapita- 
tion, and the spinal cord and optic nerve were quickly 
dissected out. All the following procedures were car- 
ried out at 0-4°C. The tissue was washed in physiol- 
ogical saline, and ground in 5 vol. lysis solution con- 
sisting of 1% Triton X-100, 130 mM NaC1 and 20 mM 
Na-phosphate (pH 6.9) in a loosely fitting Teflon- 
glass homogeniser. The homogenate was centrifuged 
at 100 000 × g for 60 min and the sediment was 
re-homogenised in the same solution. Extraction with 
the lysis solution was repeated 2 more times. The 
final sediment was suspended in a small volume of 
100 mM NaCI-1 mM EDTA-10 mM piperazine-N,N'- 
bis(2-ethanesulphonic acid) [PIPES] (pH 6.9) and the 
suspension was centrifuged at 150 000 × g for 90 min 
on 1.5 M sucrose dissolved in the same solution. The 
sediment at the bottom of the sucrose layer was 
taken as a cytoskeletal fraction. 
2.2. Preparation of intermed&te filament protein 
from cultured fibroblasts 
Fibroblasts (Don-6 and L • P3) were grown in 
Dulbecco's modified Eagle's medium (Gibco H21) in 
plastic flasks, with the addition of 5% calf serum for 
Don-6, or without serum for L • P3. On reaching con- 
fluency, the cells were treated with 1% Triton X-100 
and 150 mM NaC1 in 10 mM PIPES (pH 6.9) siriailarly 
to [8]. The cytoskeletal preparation was electropho- 
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resed in SDS-polyacrylamide g l, and the band 
representing the intermediate filament protein 
(vimentin [5]) was cut out from the gel and subjected 
to one-dimensional peptide map analysis. 
2.3. Sodium dodecyl sulphate (SDS)-polyacrylamide 
gel electrophoresis 
The cytoskeletal preparation from the spinal cord, 
optic nerve, or fibroblasts was homogenised in the 
medium consisting of 2.3% (w/v) SDS, 5 mM/3-mer- 
captoethanol, 10% (w/v) glycerol and 62.5 mM Tris- 
HC1 (pH 6.8) and heated in a boiling water bath for 
5 min. Aliquots were subjected to electrophoresis [9] 
in 10% SDS-polyacrylamide slab gels, and the gels 
were stained with 0.25% Coomassie brilliant blue 
R-250. 
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2.4. One-dimensional peptide mapping 
The protein bands to be examined were cut out 
from the stained gel. The gel slices were placed in sam- 
ple wells of a second SDS-polyacrylamide slab gel 
(15%), and overlayered with Staphylococcus aureus 
V8 protease (0.5 ng). Limited proteolysis was carried 
out directly in the stacking el during re-electropho- 
resis [10]. 
2.5. Direct detection of GFA protein by an tibody 
binding in SDS-polyacrylamide g l 
Cytoskeletal proteins were electrophoresed in a 
small-sized gel (4 cm X 8 cm), and the gel was fixed 
in water:methanol:acetic ac d(5:5:1, by vol.), and 
washed with 150 mM NaC1, 0.1% NaN3 in 50 mM 
Tris-HC1 (pH 7.5). The gel was then treated with 
anti-GFA protein antiserum raised in a rabbit against 
the degraded antigen from the human spinal cord 
[2,11] followed by fluorescein isothiocyanate-con- 
jugated IgG fraction of goat antiserum directed against 
rabbit IgG (Miles-Yeda, Israel) [12]. Photographs 
were taken under ultraviolet light. 
Fig.1. Cytoskeletal preparation isolated from the rat spinal 
cord: (A) electrophoretic banding pattern; (*) neurofi lament 
polypeptide triplet; (<1) P51 ; (B,C) negatively stained electron 
micrographs. Samples in 140 mM NaCI-10 mM PIPES (pH 
6.9) were fixed on col lodion-carbon-coated grids with 5% 
formaldehyde and 2.5% glutaraldehyde in 100 mM sodium 
cacodylate buffer (pH 7.3) and were stained with saturated 
uranyl acetate. Loosely reticulated (B) and tightly packed (C) 
fi laments are shown. Bar, 0.2 #m. 
P51 in rats, and P56 and P45 in mice (fig.2A). P56 
and P45 in the mouse optic nerve were shown to be 
copurified with the astroglial 10 nm filaments ([ 1 ]; 
we amend the M r of the larger component from 
55 000 in [1] to 56 000). In contrast to optic nerve 
cytoskeletons, those prepared from spinal cords of 
adult animals lack P56;P51 or P45 thus represents 
the major non-neuronal cytoskeletal protein in the 
spinal cord of the adult rat or mouse. 
3. Results 
3. I. Cytoskeletal proteins from the optic nerve and 
spinal cord - lnterspecies variations 
On electron microscopy, cytoskeletal fractions 
from optic nerves and spinal cords of the adult rats 
consist mainly of 10 nm Filaments of smooth contour, 
either loosely reticulated or tightly packed (rigA). On 
SDS-gel electrophoresis, the optic nerve cytoskeleton 
contains, besides the neurofilament triplet (P200, 
P160, P68), two major polypeptides, i.e., P56 and 
3.2. Occurrence of the prote& subunit of fibroblast 
intermediate filaments in tile optic nerve 
cy toskeleton 
Because of the virtual absence of P56 in the spinal 
cord cytoskeleton, we suspected that the polypeptide 
may represent the subunit of intermediate filaments 
other than astroglial 10 nm filaments, despite its 
occurrence in astroglial filaments purified from the 
optic nerve [ 1]. This possibility was explored by com- 
paring the one-dimensional peptide maps of optic 
nerve P56 and of the filament protein that was elec- 
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Fig.2. Comparison of cytoskeletal proteins between the optic 
nerve and spinal cord, and between rats and mice: (A) optic 
nerve; (B) spinal cord; (1) rats; (2) mice. In both species P56 
(o) is seen in the optic nerve, but not in the spinal cord. In 
both the optic nerve and spinal cord, P51 (t>) is present in 
rats; this is replaced by P45 (,I) in mice. 
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Fig.3. One-dimensional peptide maps of the spinal and optic 
P56 and of the fibrobtast intermediate filament protein 
(vimentin): (1) P56 from the newborn rat spinal cord; (2) 
P56 from the adult rat optic nerve; (3) P56 from the adult 
mouse optic nerve; (4) vimentin from Don-6 cells; (5) vimentin 
from L, P3 cells. Each lane contained ~- 20 ~tg of the indicated 
protein, which was subjected to a limited proteolysis with 
0.5 ng Staphylococcus aureus V8 protease. 
trophoreticaUy purified from cytoskeletons of cul- 
tured fibroblasts; the fibroblast filaments were reported 
to consist of the major polypeptide with M r 57 000 
[5] or 58 000 [4,6]. Peptide maps of  the optic nerve 
P56 from rats and mice are very similar to one another 
(fig.3, lanes 2,3), and the homology was ascertained 
also between the rodent P56 and filament protein 
from two different lines of fibroblasts (fig.3, lanes 
2 -5) .  
3.3. Identification of GFA protein in cytoskeletons 
isolated from the optic nerve and spinal cord 
Attempts have been made to characterise the 
smaller component of astroglial filament protein that 
shows the interspecies variation in its molecular weight 
(fig.2; [ 1 ]). One-dimensional peptide mapping indi- 
cates the homology between the optic nerve polypep- 
tide and spinal cord polypeptide in each species, i.e., 
P51 in rats (fig.4, lanes 1,2), and P45 in mice (rigA, 
lanes 3,4). However, the peptide maps exhibit many 
dissimilarities between the rat and mouse. 
In the next step, the immunoreactivity of P51 and 
P45 with anti-GFA protein antiserum was examined. 
After electrophoresis of the spinal cytoskeletal frac- 
tion, the gel was treated with rabbit anti-GFA protein 
antiserum, and then with fluorescein isothiocyanate- 
conjugated goat IgG directed against rabbit IgG. Sig- 
nificant fluorescence was produced by P51 in rats and 
by P45 in mice (fig.4B), indicating that these are the 
GFA protein despite their interspecies variations in 
M r and in one-dimensional peptide maps. In mice, a 
weaker fluorescence was seen also with P43 (fig.4B, 
lane 2), which seems to be related to the presence of 
tiffs polypeptide in the cytoskeletal preparation from 
the mouse spinal cord (fig.2B, lane 2). The one-dimen- 
sional peptide map of this polypeptide is homologous 
to that of actin purified from the mouse brain (not 
shown). 
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Fig.4. Species difference in GFA protein between rats and 
mice: (A) one-dimensional peptide maps of rat P51 (spinal 
(1); optic (2)) and mouse P45 (spinal (3); optic (4)); (B) 
identification of the rat P51 and mouse P45 as GFA protein. 
The spinal cytoskeletal preparation from the rat (1) and 
mouse (2) was electrophoresed in a small gel, and the gel was 
treated with rabbit anti-GFA protein antiserum, and further 
with fluorescein sothiocyanate-conjugated goat IgG directed 
against rabbit IgG. Electrophoretic mobility of P51 in rats 
6>) and P45 in mice (,~) was determined by comparison with 
the equivalent lanes electrophoresed in the same gel and 
stained with Coomassie blue. 
1 2 3 4 
Fig.5. Maturational changes in the composition ofcytoskeletal 
proteins in the rat spinal cord: (o) P56 (vimentin); (<1) P51 
(GFA protein); (1 4) correspond to 2 day-, 2 week-, 4 week- 
and 10 week-old rats, respectively. 
3.4. Postnatal changes in the composition of 
cytoskeletal proteins 
P56 is present in the optic nerve cytoskeleton of 
the adult animal, but is almost undetectable in the 
spinal cord cytoskeleton of the adult animals (fig.2). 
However, P56 does predominate in the spinal cord 
cytoskeleton isolated from 2 day-old rats, where the 
level of GFA protein is still very low (fig.5, lane 1). 
The homology between the spinal P56 and optic P56 
is established by one-dimensional peptide mapping 
(fig.3, lanes 1,2). The spinal P56 rapidly declines 
during the subsequent maturational stage, and becomes 
almost undetectable in the adult spinal cord, while 
the adult level of  GFA protein seems to be attained 
within 2 weeks at latest (fig.5). 
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4. Discussion 
We have shown that the astroglial 10 nm fdaments 
isolated from degenerated optic nerves of adult mice 
are composed of two polypeptides [ 1 ]. Here, the 
larger component is shown to be homologous to the 
subunit of the intermediate filament protein of 
fibroblast origin (vimentin), and the smaller compo- 
nent to GFA protein. The finding is in accord with 
the recent immunocytochemical demonstration of
the coexistence of vimentin and GFA protein in 
astrocytes in situ [13,14], and in glioma cells in cul- 
ture [15]. In [7] vimentin and GFA protein were 
reported to coexist in the rat optic nerves undergoing 
Wallerian degeneration. It is thus clear that astrocytes 
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in situ or in culture are one of the members of a wide 
variety of cell lines where vimentin occurs simultane- 
ously with other kinds of intermediate filament pro- 
teins, i.e., desmin and keratins (review [16]). 
Detailed immunocytochemical studies [ 13] have 
demonstrated that vimentin in astrocytes and glial 
precursors i expressed well before the onset of GFA 
protein and might therefore serve as an early marker 
of glial differentiation. Here, the relative dominance 
of vimentin vs GFA protein in the rat spinal cord 
seems to alter some time during 2 days and 2 weeks 
after birth (fig.5). In [7] vimentin was reported to be 
the major protein in the newborn and GFA the major 
protein in the adult cytoskeleton from rats. However, 
the question remains whether the earlier expression 
and later decline of vimentin represent events occur- 
ring inside the astrocytes in the spinal cord, because 
vimentin is immunocytochemically demonstrated not 
only in astrocytes, but also in fibroblasts, cells of 
larger vessels, and in ependymal cells [13]. In the 
optic nerve, the coexistence of GFA protein and 
vimentin in astrocytes seems certain, because these 
polypeptides are copurified with astroglial I0 nm 
filaments [1 ]. Early expression of vimentin and its 
decline at later stages have been reported in cultured 
muscle cells [17], though other workers failed to 
observe the latter decline [18]. 
Neurofilaments i olated from the rat sciatic nerve 
are composed exclusively of 3 polypeptides, P200, 
P160 and P68 [19,20], present in relative molar pro- 
portion comparable with that of nerve in situ [21]. 
Neurofilament preparations i olated from the central 
nervous ystem contain, besides the triplet, several 
additional polypeptides among which the major is 
a polypeptide with M r ~ 50 000 [22-24].  Although 
this polypeptide has generally been suspected to be of 
glial origin, direct evidence for this has been lacking, 
except for a recent demonstration that the antiserum 
raised against 49 000 M r polypeptide recovered in a 
filament preparation from the human brain strongly 
stained Bergmann glial fibres and astroglial cells in 
white matter fibre tract in the granular layer of the 
cerebellum [14]. This demonstration of GFA protein 
and the neurofilament triplet in the spinal cord cyto- 
skeleton, together with the demonstration of GFA 
proteinin the purified astroglial filaments [1], directly 
indicates that astroglial filaments are inevitably 
copurified with neurofilaments when the central ner- 
vous system is used as starting material. 
Interspecies variations of GFA protein do not 
seem to have been properly documented, though the 
M r reported for GFA protein by different workers 
varies to a considerable extent (e.g. [3,11,25,26]). 
This study clearly indicates the occurrence of inter- 
species variation of the GFA protein in its M r and in 
its peptide maps between 2 rodent species (fig.2,4); 
in guinea pigs, the M r of GFA protein was estimated 
to be 52 000 (not shown). 
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